Biologics Outsourcing Market with COVID-19 Impact Analysis, By Product Type (Antibody, Recombinant, Protein, Vaccines, Others), By Application (Therapeutics, Diagnostics, Research), By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
The Biologics Outsourcing Market size was valued at USD 80,410.3 million in 2022, expanding at a CAGR of 18.7% from 2023 to 2030.
Biologics outsourcing refers to the practice of delegating specific tasks or functions related to the development, manufacturing, or testing of biologic products to external service providers. Biologics, which include proteins, antibodies, vaccines, and other complex biological substances, often require specialized expertise, infrastructure, and resources for their production and analysis. Outsourcing allows biopharmaceutical companies to leverage the capabilities and resources of contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), and other service providers. These external partners offer expertise in areas such as cell line development, process development, manufacturing, quality control, regulatory compliance, and clinical research. Biologics outsourcing enables companies to access specialized capabilities, optimize resources, accelerate development timelines, and focus on their core competencies.
Biologics Outsourcing Market- Market Dynamics
One key driver is the growing complexity of biologic products. Biologics often require specialized expertise and infrastructure for their development, manufacturing, and testing. Outsourcing allows companies to access the specialized knowledge and capabilities of contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) that have invested in advanced technologies and facilities. Cost considerations are another driver. Biologic development and manufacturing can be capital-intensive, requiring substantial investments in infrastructure, equipment, and skilled personnel. Outsourcing certain functions allows companies to optimize costs by leveraging the existing capabilities of external service providers and avoiding the need for significant upfront investments.
Additionally, outsourcing offers flexibility and scalability. Companies can quickly scale up or down their biologics programs by engaging with external partners, avoiding the need to maintain extensive in-house capabilities that may be underutilized or require significant investments. Furthermore, outsourcing provides access to specialized talent, especially in niche areas such as cell line development, analytical testing, and regulatory affairs. Collaboration with external experts enables companies to tap into a broader pool of knowledge and experience, enhancing their overall capabilities and efficiency.
One restraint of biologics outsourcing is the potential loss of control over critical aspects of the development and manufacturing process. Companies may face challenges in maintaining oversight, ensuring quality control, and managing intellectual property when relying on external service providers.
Biologics Outsourcing Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. The demand for biologics outsourcing in North America has witnessed substantial growth in recent years. North America, particularly the United States, is a prominent hub for biopharmaceutical research, development, and manufacturing. The region hosts numerous biotechnology and pharmaceutical companies that are actively engaged in the development of biologics. Factors driving the demand for biologics outsourcing in North America include the increasing complexity of biologic products, the need for specialized expertise and infrastructure, and cost optimization. Biopharmaceutical companies often seek external partners, such as contract development and manufacturing organizations (CDMOs), to access advanced technologies, specialized capabilities, and flexible manufacturing capacities. Additionally, the stringent regulatory environment in North America necessitates compliance with strict quality standards, and outsourcing certain functions can help companies navigate the regulatory landscape effectively.
Biologics Outsourcing Market- Competitive Landscape:
The competitive landscape of biologics outsourcing is characterized by a diverse range of service providers, including contract development and manufacturing organizations (CDMOs), contract research organizations (CROs), and specialized service providers. Large CDMOs, such as Lonza, Catalent, and Patheon, dominate the market with their extensive infrastructure, global reach, and comprehensive service offerings. These companies often provide end-to-end solutions, covering the entire biologics development and manufacturing process. Specialized CROs, on the other hand, focus on specific areas of expertise, such as cell line development, analytical testing, or clinical research. These niche service providers offer specialized capabilities and cater to the unique needs of biopharmaceutical companies. Moreover, collaborations and strategic partnerships between biopharmaceutical companies and service providers contribute to the competitive landscape, as these alliances foster the exchange of knowledge, resources, and technologies, allowing for comprehensive and efficient outsourcing solutions. For instance, in 2023, Boehringer Ingelheim opens a USD386m German R&D plant. The Biologics Development Center (BDC) will develop antibodies and therapeutic proteins and manufacture substances for clinical trials, says Boehringer Ingelheim.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BIOLOGICS OUTSOURCING MARKET KEY PLAYERS
- Boehringer Ingelheim
- Catalent
- GenScript
- Innovent Biologics
- Syngene
- Shanghai Medicilon
- GL Biochem Corporation
- GVK Biosciences Private
- Horizon Discovery Group
- Selexis
- Lonza
- Abzena
- Adimab
GLOBAL BIOLOGICS OUTSOURCING MARKET, BY PRODUCT TYPE
- Antibody
- Recombinant
- Protein
- Vaccines
- Others
GLOBAL BIOLOGICS OUTSOURCING MARKET, BY APPLICATION
- Therapeutics
- Diagnostics
- Research
GLOBAL BIOLOGICS OUTSOURCING MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Biologics Outsourcing Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Biologics Outsourcing Market Snippet by Product Type
2.1.2. Biologics Outsourcing Market Snippet by Application
2.1.3. Biologics Outsourcing Market Snippet by Country
2.1.4. Biologics Outsourcing Market Snippet by Region
2.2. Competitive Insights
3. Biologics Outsourcing Key Market Trends
3.1. Biologics Outsourcing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Biologics Outsourcing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Biologics Outsourcing Market Opportunities
3.4. Biologics Outsourcing Market Future Trends
4. Biologics Outsourcing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Biologics Outsourcing Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Biologics Outsourcing Market Landscape
6.1. Biologics Outsourcing Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Biologics Outsourcing Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
7.1.2. Antibody
7.1.3. Recombinant
7.1.4. Protein
7.1.5. Vaccines
7.1.6. Others
8. Biologics Outsourcing Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
8.1.2. Therapeutics
8.1.3. Diagnostics
8.1.4. Research
9. Biologics Outsourcing Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2. North America
9.2.1. Overview
9.2.2. Biologics Outsourcing Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Biologics Outsourcing Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.10. Russia
9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.11. Netherlands
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.12. Sweden
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.13. Poland
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.14. Rest of Europe
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Biologics Outsourcing Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Biologics Outsourcing Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Biologics Outsourcing Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Biologics Outsourcing Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Boehringer Ingelheim
10.2.2. Catalent
10.2.3. GenScript
10.2.4. Innovent Biologics
10.2.5. Syngene
10.2.6. Shanghai Medicilon
10.2.7. GL Biochem Corporation
10.2.8. GVK Biosciences Private
10.2.9. Horizon Discovery Group
10.2.10. Selexis
10.2.11. Lonza
10.2.12. Abzena
10.2.13. Adimab
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
